Dian Gu, PhD

Title(s)Postdoctoral Scholar, Medicine
SchoolSchool of Medicine
AddressLocation Required, #001
Phone415-514-8627
vCardDownload vCard

    Collapse Biography 
    Collapse Education and Training
    Nanjing Medical University, ChinaBSPublic Health Administration
    Emory University, AtlantaMPHBehavioral Sciences and Health Education
    The University of Texas, HoustonPHDHealth Economics/Health Services Research

    Collapse Overview 
    Collapse Overview
    Dian Gu is a postdoctoral fellow at Center for Tobacco Control Research and Education (CTCRE), UCSF. She received her PhD in Health Economics/Health Services Research from the University of Texas Health Science Center at Houston. Along with her PhD study, she was a PhD trainee in MD Anderson Cancer Center. In that role, she gained experience in applying health economics to cancer research, collaborating on manuscripts with clinicians on multiple projects concerned with cancer patients’ healthcare utilization, expenditures, and health outcomes. After finishing her PhD, she joined the Institute for Health & Aging at UCSF. In the work there, she mainly performed data analyses and collaborated on manuscripts with professors on a wide range of tobacco economics research projects. During the fellowship at CTCRE, Dian is interested in 1) estimating economic costs attributable to tobacco use of cancer and other tobacco-related illnesses; 2) examining the role of tobacco use in cancer prevention and development; 3) evaluating the economic impact of different tobacco control policies on vulnerable populations.

    Collapse Research 
    Collapse Research Activities and Funding
    Evaluation of a smoking cessation intervention for people experiencing homelessness
    California Tobacco Related Diseases Research Program T33FT6588Jul 1, 2023 - Jun 30, 2025
    Role: Principal Investigator

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Cost-effectiveness analysis of ovarian function preservation with GnRH agonist during chemotherapy in premenopausal women with early breast cancer. Hum Reprod. 2023 06 01; 38(6):1099-1110. Huang Y, Huang X, Huang X, Lin S, Luo S, Gu D, Weng X, Xu X. PMID: 37075316.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    2. Racial and sociodemographic predictors of COVID-19 compared with influenza, appendicitis, and all-cause hospitalization: retrospective cohort analysis. Ethn Health. 2023 08; 28(6):836-852. Raphael E, Azar KMJ, Gu D, Shen Z, Rubinsky A, Wang M, Pantell M, Lyles CR, Fernandez A, Bibbins-Domingo K, Pressman A, Nasrallah C, Hamad R. PMID: 36907661.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    3. Association between e-cigarette use and food insecurity among low-income adults. Tob Control. 2023 08; 32(e2):e212-e219. Gu D, Max WB, Yao T, Wang Y, Keeler C, Sung HY. PMID: 35279644; PMCID: PMC9464793.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    4. Cost-effectiveness of adding daratumumab or bortezomib to lenalidomide plus dexamethasone for newly diagnosed multiple myeloma. J Manag Care Spec Pharm. 2021 Dec; 27(12):1691-1702. Narsipur N, Bulla S, Yoo C, Do B, Tran K, Gu D, Zhong L, Wilson L. PMID: 34818089; PMCID: PMC10391124.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    5. The Association of California's Proposition 56 Tobacco Tax Increase With Smoking Behavior Across Racial and Ethnic Groups and by Income. Nicotine Tob Res. 2021 11 05; 23(12):2091-2101. Keeler C, Wang Y, Max W, Yao T, Gu D, Sung HY. PMID: 34137859.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    6. First-Line Durvalumab in Addition to Etoposide and Platinum for Extensive-Stage Small Cell Lung Cancer: A U.S.-Based Cost-Effectiveness Analysis. Oncologist. 2021 11; 26(11):e2013-e2020. Lin S, Luo S, Gu D, Li M, Rao X, Wang C, Huang P, Xu X, Weng X. PMID: 34431578; PMCID: PMC8571771.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    7. Prolonged Opioid Use After Surgery for Early-Stage Breast Cancer. Oncologist. 2020 10; 25(10):e1574-e1582. Shen C, Thornton JD, Gu D, Dodge D, Zhou S, He W, Zhao H, Giordano SH. PMID: 32390251; PMCID: PMC7543235.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    8. Association between depression and healthcare expenditures among elderly cancer patients. BMC Psychiatry. 2020 03 23; 20(1):131. Gu D, Morgan RO, Li R, Weber ES, Shen C. PMID: 32293366; PMCID: PMC7092441.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    9. Factors Associated With Hospital Decisions to Purchase Robotic Surgical Systems. MDM Policy Pract. 2020 Jan-Jun; 5(1):2381468320904364. Shen C, Gu D, Klein R, Zhou S, Shih YT, Tracy T, Soybel D, Dillon P. PMID: 32072012; PMCID: PMC6997967.
      View in: PubMed   Mentions: 3  
    10. Assessing the Importance of Factors Associated with Cost-Related Nonadherence to Medication for Older US Medicare Beneficiaries. Drugs Aging. 2019 12; 36(12):1111-1121. Gu D, Shen C. PMID: 31686403.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    11. Racial Differences in the Incidence and Survival of Patients With Neuroendocrine Tumors. Pancreas. 2019 Nov/Dec; 48(10):1373-1379. Shen C, Gu D, Zhou S, Xu Y, Sarshekeh AM, Halperin D, Shih YT, Yao JC, Dasari A. PMID: 31688604.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    12. Cost-Related Medication Nonadherence and Cost-Reduction Strategies Among Elderly Cancer Survivors with Self-Reported Symptoms of Depression. Popul Health Manag. 2020 04; 23(2):132-139. Gu D, Shen C. PMID: 31287770.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    13. Impact of serious mental illness on the treatment and mortality of older patients with locoregional high-grade (nonmetastatic) prostate cancer: retrospective cohort analysis of 49 985 SEER-Medicare patients diagnosed between 2006 and 2013. Cancer Med. 2019 05; 8(5):2612-2622. Fried DA, Sadeghi-Nejad H, Gu D, Zhou S, He W, Giordano SH, Pentakota SR, Demissie K, Helmer D, Shen C. PMID: 30945473; PMCID: PMC6536920.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    14. Pre-existing Symptoms and Healthcare Utilization Prior to Diagnosis of Neuroendocrine Tumors: A SEER-Medicare Database Study. Sci Rep. 2018 11 15; 8(1):16863. Shen C, Dasari A, Xu Y, Zhou S, Gu D, Chu Y, Halperin DM, Shih YT, Yao JC. PMID: 30442902; PMCID: PMC6238007.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    15. Costs of Cancer Care for Elderly Patients with Neuroendocrine Tumors. Pharmacoeconomics. 2018 08; 36(8):1005-1013. Shen C, Dasari A, Gu D, Chu Y, Zhou S, Xu Y, Halperin D, Fu S, Yao JC, Shih YT. PMID: 29682693.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    Dian's Networks
    Concepts (75)
    Derived automatically from this person's publications.
    _
    Co-Authors (13)
    People in Profiles who have published with this person.
    _
    Similar People (60)
    People who share similar concepts with this person.
    _
    Same Department
    Search Department
    _